National Study on the Prevalence of Catheter-Related Venous Thrombosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta
About this trial
The aim is to determine the prevalence of catheter-related thrombosis (CRT) in hospitalized patients carrying PICC, FICC, CICC, and midline catheters through a multicenter, standardized prevalence study. To achieve this, a cross-sectional study with prospective data collection will be conducted, including, through consecutive sampling to minimize selection bias, all hospitalized patients over 18 years of age from both general wards and critical care units who have had one of these catheters in place for at least 7 days. During data collection, an ultrasound examination of the catheter insertion site will be performed in order to rule out the presence of thrombotic complications.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All hospitalized patients aged ≥18 years from all hospital wards, including critical care units, who are carriers of a midline, FICC, PICC, or CICC catheter with a dwell time of at least 7 days will be included.
Disqualifiers
Patients who do not provide informed consent for the ultrasound assessment.
Trial population
The study will be conducted across the following centers: Complejo Hospitalario Universitario Nuestra Señora de Candelaria, Hospital del Mar, Hospital Sant Joan de Déu-Althaia, Hospital Universitari Joan XXIII, Hospital Universitario de Navarra, Hospital Universitario Doctor Josep Trueta, Hospital Universitario Donostia, Hospital Universitario Mutua Terrassa, Hospital Universitario Son Espases, Policlínica Gipuzkoa, and Hospital de Navarra. Participation will include hospital institutions with an Infusion and Vascular Access Unit (IVAU) that has institutionally recognized expertise in the detection of catheter-related thrombosis (CRT).
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Overall prevalence of catheter-related thrombosis
Number of patients with CRT / total number of patients evaluated) × 100
Time frame
From the beginning of the cutoff to the end of the cutoff at 4 weeksSecondary outcomes
1
Symptomatic CRT
(Number of CRT cases with ≥1 clinical sign / total number of CRT cases) × 100
Time frame
From the beginning of the cutoff to the end of the cutoff at 4 weeks2
Asymptomatic CRT
(Number of CRT cases without clinical signs / total number of CRT cases) × 100
Time frame
From the beginning of the cutoff to the end of the cutoff at 4 weeks3
Superficial CRT
Number of superficial CRT cases / total number of CRT cases) × 100
Time frame
From the beginning of the cutoff to the end of the cutoff at 4 weeks4
Deep CRT
Number of deep CRT cases / total number of CRT cases) × 100
Time frame
From the beginning of the cutoff to the end of the cutoff at 4 weeksLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Lead sponsor
Hospital del Mar Research Institute (IMIM)
Collaborator
Althaia Xarxa Assistencial Universitària de Manresa
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: